{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:17:00Z","timestamp":1790302620952,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T00:00:00Z","timestamp":1427587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1177-1","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T06:50:07Z","timestamp":1427611807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The leukemia inhibitory factor (LIF) and p21 mediate the TGF\u03b2 tumor suppressive effects in human cutaneous melanoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Laure","family":"Humbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Ghozlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Canaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,29]]},"reference":[{"issue":"16","key":"1177_CR1","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol Official J American Soc Clin Oncol. 2001;19(16):3635\u201348.","journal-title":"J Clin Oncol Official J American Soc Clin Oncol"},{"issue":"4","key":"1177_CR2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","volume":"2","author":"AN Houghton","year":"2002","unstructured":"Houghton AN, Polsky D. Focus on melanoma. Cancer Cell. 2002;2(4):275\u20138.","journal-title":"Cancer Cell"},{"issue":"6892","key":"1177_CR3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949\u201354.","journal-title":"Nature"},{"issue":"2","key":"1177_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1751-1097.2007.00254.x","volume":"84","author":"P Lopez-Bergami","year":"2008","unstructured":"Lopez-Bergami P, Fitchman B, Ronai Z. Understanding signaling cascades in melanoma. Photochem Photobiol. 2008;84(2):289\u2013306.","journal-title":"Photochem Photobiol"},{"issue":"2","key":"1177_CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1755-148X.2008.00450.x","volume":"21","author":"D Javelaud","year":"2008","unstructured":"Javelaud D, Alexaki VI, Mauviel A. Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res. 2008;21(2):123\u201332.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1177_CR6","first-page":"69","volume":"5","author":"L Humbert","year":"2010","unstructured":"Humbert L, Neel JC, Lebrun JJ. Targeting TGF-beta signaling in human cancer therapy. Trends Cell Mol Biol. 2010;5:69\u2013107.","journal-title":"Trends Cell Mol Biol"},{"issue":"5","key":"1177_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.molcel.2004.07.016","volume":"15","author":"BM Chacko","year":"2004","unstructured":"Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, et al. Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Mol Cell. 2004;15(5):813\u201323.","journal-title":"Mol Cell"},{"issue":"1","key":"1177_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/mend.13.1.0218","volume":"13","author":"JJ Lebrun","year":"1999","unstructured":"Lebrun JJ, Takabe K, Chen Y, Vale W. Roles of pathway-specific and inhibitory Smads in activin receptor signaling. Mol Endocrinol. 1999;13(1):15\u201323.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"1177_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J. TGFbeta in cancer. Cell. 2008;134(2):215\u201330.","journal-title":"Cell"},{"issue":"5","key":"1177_CR10","first-page":"R127","volume":"14","author":"M Dai","year":"2012","unstructured":"Dai M, Al-Odaini A, Arakelian A, Rabbani SA, Ali S, Lebrun JJ. A novel function for p21Cip1 and the transcriptional regulator P\/CAF as critical regulators of TGF\u00df mediated breast cancer cell migration and invasion. Breast Cancer Res. 2012;14(5):R127.","journal-title":"Breast Cancer Res"},{"key":"1177_CR11","first-page":"1","volume":"2012","author":"JJ Lebrun","year":"2012","unstructured":"Lebrun JJ. The dual role of TGF in human cancer: from tumor suppression to cancer metastasis. ISRN Molecular Biol. 2012;2012:1\u201328.","journal-title":"ISRN Molecular Biol"},{"issue":"2","key":"1177_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cellsig.2012.10.011","volume":"25","author":"L Humbert","year":"2013","unstructured":"Humbert L, Lebrun JJ. TGF-beta inhibits human cutaneous melanoma cell migration and invasion through regulation of the plasminogen activator system. Cell Signal. 2013;25(2):490\u2013500.","journal-title":"Cell Signal"},{"issue":"1","key":"1177_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4827(03)00336-7","volume":"291","author":"L Ramont","year":"2003","unstructured":"Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Exp Cell Res. 2003;291(1):1\u201310.","journal-title":"Exp Cell Res"},{"issue":"2","key":"1177_CR14","first-page":"575","volume":"54","author":"U Rodeck","year":"1994","unstructured":"Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, et al. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res. 1994;54(2):575\u201381.","journal-title":"Cancer Res"},{"issue":"2","key":"1177_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1097-4652(199902)178:2<179::AID-JCP7>3.0.CO;2-5","volume":"178","author":"K Krasagakis","year":"1999","unstructured":"Krasagakis K, Kruger-Krasagakes S, Fimmel S, Eberle J, Tholke D, von der Ohe M, et al. Desensitization of melanoma cells to autocrine TGF-beta isoforms. J Cell Physiol. 1999;178(2):179\u201387.","journal-title":"J Cell Physiol"},{"issue":"2","key":"1177_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5021\/ad.2013.25.2.135","volume":"25","author":"CY Perrot","year":"2013","unstructured":"Perrot CY, Javelaud D, Mauviel A. Insights into the transforming growth factor-beta signaling pathway in cutaneous melanoma. Annals Dermatology. 2013;25(2):135\u201344.","journal-title":"Annals Dermatology"},{"issue":"3","key":"1177_CR17","first-page":"547","volume":"59","author":"U Rodeck","year":"1999","unstructured":"Rodeck U, Nishiyama T, Mauviel A. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells. Cancer Res. 1999;59(3):547\u201350.","journal-title":"Cancer Res"},{"issue":"18","key":"1177_CR18","first-page":"4815","volume":"51","author":"AP Albino","year":"1991","unstructured":"Albino AP, Davis BM, Nanus DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res. 1991;51(18):4815\u201320.","journal-title":"Cancer Res"},{"issue":"6B","key":"1177_CR19","first-page":"2565","volume":"14","author":"K Krasagakis","year":"1994","unstructured":"Krasagakis K, Garbe C, Schrier PI, Orfanos CE. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res. 1994;14(6B):2565\u201371.","journal-title":"Anticancer Res"},{"issue":"1","key":"1177_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1523-1747.ep12477822","volume":"97","author":"U Rodeck","year":"1991","unstructured":"Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B, et al. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol. 1991;97(1):20\u20136.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"1177_CR21","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/carcin\/bgq155","volume":"31","author":"A Lasfar","year":"2010","unstructured":"Lasfar A, Cohen-Solal KA. Resistance to transforming growth factor beta-mediated tumor suppression in melanoma: are multiple mechanisms in place? Carcinogenesis. 2010;31(10):1710\u20137.","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"1177_CR22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(97)01015-9","volume":"776","author":"I Matsuoka","year":"1997","unstructured":"Matsuoka I, Nakane A, Kurihara K. Induction of LIF-mRNA by TGF-beta 1 in Schwann cells. Brain Res. 1997;776(1\u20132):170\u201380.","journal-title":"Brain Res"},{"issue":"4","key":"1177_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","volume":"15","author":"S Penuelas","year":"2009","unstructured":"Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I, et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 2009;15(4):315\u201327.","journal-title":"Cancer Cell"},{"issue":"2","key":"1177_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1684\/ecn.2009.0148","volume":"20","author":"M Trouillas","year":"2009","unstructured":"Trouillas M, Saucourt C, Guillotin B, Gauthereau X, Taupin JL, Moreau JF, et al. The LIF cytokine: towards adulthood. Eur Cytokine Netw. 2009;20(2):51\u201362.","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"1177_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-011-9261-7","volume":"8","author":"ME Mathieu","year":"2012","unstructured":"Mathieu ME, Saucourt C, Mournetas V, Gauthereau X, Theze N, Praloran V, et al. LIF-dependent signaling: new pieces in the Lego. Stem Cell Rev. 2012;8(1):1\u201315.","journal-title":"Stem Cell Rev"},{"issue":"2 Pt 2","key":"1177_CR26","first-page":"279","volume":"30","author":"RC McKenzie","year":"2004","unstructured":"McKenzie RC, Szepietowski J. Cutaneous leukemia inhibitory factor and its potential role in the development of skin tumors. Dermatol Surg. 2004;30(2 Pt 2):279\u201390.","journal-title":"Dermatol Surg"},{"issue":"33","key":"1177_CR27","doi-asserted-by":"crossref","first-page":"21137","DOI":"10.1074\/jbc.273.33.21137","volume":"273","author":"T Bellido","year":"1998","unstructured":"Bellido T, O\u2019Brien CA, Roberson PK, Manolagas SC. Transcriptional activation of the p21(WAF1, CIP1, SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem. 1998;273(33):21137\u201344.","journal-title":"J Biol Chem"},{"issue":"13","key":"1177_CR28","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1158\/0008-5472.CAN-04-3734","volume":"66","author":"H Halfter","year":"2006","unstructured":"Halfter H, Friedrich M, Resch A, Kullmann M, Stogbauer F, Ringelstein EB, et al. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. Cancer Res. 2006;66(13):6530\u20139.","journal-title":"Cancer Res"},{"issue":"29","key":"1177_CR29","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1038\/sj.onc.1209432","volume":"25","author":"E De la Cueva","year":"2006","unstructured":"De la Cueva E, Garcia-Cao I, Herranz M, Lopez P, Garcia-Palencia P, Flores JM, et al. Tumorigenic activity of p21Waf1\/Cip1 in thymic lymphoma. Oncogene. 2006;25(29):4128\u201332.","journal-title":"Oncogene"},{"issue":"4","key":"1177_CR30","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1007\/s11033-010-0423-5","volume":"38","author":"JI Heo","year":"2011","unstructured":"Heo JI, Oh SJ, Kho YJ, Kim JH, Kang HJ, Park SH, et al. ERK mediates anti-apoptotic effect through phosphorylation and cytoplasmic localization of p21Waf1\/Cip1\/Sdi in response to DNA damage in normal human embryonic fibroblast (HEF) cells. Mol Biol Rep. 2011;38(4):2785\u201391.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"1177_CR31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.onc.1202021","volume":"17","author":"A Suzuki","year":"1998","unstructured":"Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 1998;17(8):931\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"1177_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3835(00)00586-3","volume":"161","author":"H Lincet","year":"2000","unstructured":"Lincet H, Poulain L, Remy JS, Deslandes E, Duigou F, Gauduchon P, et al. The p21(cip1\/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett. 2000;161(1):17\u201326.","journal-title":"Cancer Lett"},{"issue":"1","key":"1177_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/jhep.2002.33899","volume":"36","author":"L Qiao","year":"2002","unstructured":"Qiao L, McKinstry R, Gupta S, Gilfor D, Windle JJ, Hylemon PB, et al. Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53. Hepatology. 2002;36(1):39\u201348.","journal-title":"Hepatology"},{"issue":"2","key":"1177_CR34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/excr.1999.4644","volume":"253","author":"KH Kang","year":"1999","unstructured":"Kang KH, Kim WH, Choi KH. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res. 1999;253(2):403\u201312.","journal-title":"Exp Cell Res"},{"issue":"8","key":"1177_CR35","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4049\/jimmunol.164.8.4032","volume":"164","author":"R Hingorani","year":"2000","unstructured":"Hingorani R, Bi B, Dao T, Bae Y, Matsuzawa A, Crispe IN. CD95\/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-1\/WAF-1, which promotes apoptosis. J Immunol. 2000;164(8):4032\u20136.","journal-title":"J Immunol"},{"issue":"15","key":"1177_CR36","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1101\/gad.9.15.1831","volume":"9","author":"I Reynisdottir","year":"1995","unstructured":"Reynisdottir I, Polyak K, Iavarone A, Massague J. Kip\/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 1995;9(15):1831\u201345.","journal-title":"Genes Dev"},{"issue":"12","key":"1177_CR37","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","volume":"92","author":"MB Datto","year":"1995","unstructured":"Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A. 1995;92(12):5545\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6494","key":"1177_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994;371(6494):257\u201361.","journal-title":"Nature"},{"issue":"8","key":"1177_CR39","first-page":"3088","volume":"8","author":"RJ Coffey Jr","year":"1988","unstructured":"Coffey Jr RJ, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol Cell Biol. 1988;8(8):3088\u201393.","journal-title":"Mol Cell Biol"},{"key":"1177_CR40","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1038\/cddis.2012.146","volume":"3","author":"J Korah","year":"2012","unstructured":"Korah J, Falah N, Lacerte A, Lebrun JJ. A transcriptionally active pRb-E2F1-P\/CAF signaling pathway is central to TGFbeta-mediated apoptosis. Cell Death Dis. 2012;3:e407.","journal-title":"Cell Death Dis"},{"issue":"48","key":"1177_CR41","doi-asserted-by":"crossref","first-page":"28623","DOI":"10.1074\/jbc.270.48.28623","volume":"270","author":"MB Datto","year":"1995","unstructured":"Datto MB, Yu Y, Wang XF. Functional analysis of the transforming growth factor beta responsive elements in the WAF1\/Cip1\/p21 promoter. J Biol Chem. 1995;270(48):28623\u20138.","journal-title":"J Biol Chem"},{"issue":"10","key":"1177_CR42","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nm.2940","volume":"18","author":"D Chen","year":"2012","unstructured":"Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med. 2012;18(10):1511\u20137.","journal-title":"Nat Med"},{"issue":"6","key":"1177_CR43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9(6):400\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1177_CR44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1134\/S000629791206003X","volume":"77","author":"VS Romanov","year":"2012","unstructured":"Romanov VS, Pospelov VA, Pospelova TV. Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Mosc). 2012;77(6):575\u201384.","journal-title":"Biochemistry (Mosc)"},{"issue":"1\u20133","key":"1177_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrrev.2010.01.009","volume":"704","author":"O Cazzalini","year":"2010","unstructured":"Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res. 2010;704(1\u20133):12\u201320.","journal-title":"Mutat Res"},{"issue":"2","key":"1177_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/biof.26","volume":"35","author":"AL Gartel","year":"2009","unstructured":"Gartel AL. p21(WAF1\/CIP1) and cancer: a shifting paradigm? Biofactors. 2009;35(2):161\u20134.","journal-title":"Biofactors"},{"issue":"2","key":"1177_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","volume":"14","author":"A Besson","year":"2008","unstructured":"Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14(2):159\u201369.","journal-title":"Dev Cell"},{"issue":"6","key":"1177_CR48","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S1097-2765(03)00180-1","volume":"11","author":"S Huang","year":"2003","unstructured":"Huang S, Shu L, Dilling MB, Easton J, Harwood FC, Ichijo H, et al. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53\/p21(Cip1). Mol Cell. 2003;11(6):1491\u2013501.","journal-title":"Mol Cell"},{"issue":"6585","key":"1177_CR49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/381804a0","volume":"381","author":"J Shim","year":"1996","unstructured":"Shim J, Lee H, Park J, Kim H, Choi EJ. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 1996;381(6585):804\u20136.","journal-title":"Nature"},{"issue":"24","key":"1177_CR50","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1038\/sj.onc.1202693","volume":"18","author":"R Fotedar","year":"1999","unstructured":"Fotedar R, Brickner H, Saadatmandi N, Rousselle T, Diederich L, Munshi A, et al. Effect of p21waf1\/cip1 transgene on radiation induced apoptosis in T cells. Oncogene. 1999;18(24):3652\u20138.","journal-title":"Oncogene"},{"issue":"2","key":"1177_CR51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0012-1606(92)90174-F","volume":"151","author":"AG Smith","year":"1992","unstructured":"Smith AG, Nichols J, Robertson M, Rathjen PD. Differentiation inhibiting activity (DIA\/LIF) and mouse development. Dev Biol. 1992;151(2):339\u201351.","journal-title":"Dev Biol"},{"issue":"3\u20134","key":"1177_CR52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/08830189809043003","volume":"16","author":"JL Taupin","year":"1998","unstructured":"Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF. Leukemia inhibitory factor: part of a large ingathering family. Int Rev Immunol. 1998;16(3\u20134):397\u2013426.","journal-title":"Int Rev Immunol"},{"issue":"3","key":"1177_CR53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.1040740303","volume":"74","author":"Y Ichikawa","year":"1969","unstructured":"Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969;74(3):223\u201334.","journal-title":"J Cell Physiol"},{"issue":"35","key":"1177_CR54","doi-asserted-by":"crossref","first-page":"24965","DOI":"10.1074\/jbc.274.35.24965","volume":"274","author":"J Aubert","year":"1999","unstructured":"Aubert J, Dessolin S, Belmonte N, Li M, McKenzie FR, Staccini L, et al. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem. 1999;274(35):24965\u201372.","journal-title":"J Biol Chem"},{"issue":"9","key":"1177_CR55","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCRESAHA.107.156786","volume":"101","author":"J Rajasingh","year":"2007","unstructured":"Rajasingh J, Bord E, Hamada H, Lambers E, Qin G, Losordo DW, et al. STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction. Circ Res. 2007;101(9):910\u20138.","journal-title":"Circ Res"},{"issue":"10","key":"1177_CR56","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1074\/jbc.M508969200","volume":"281","author":"T Mohri","year":"2006","unstructured":"Mohri T, Fujio Y, Maeda M, Ito T, Iwakura T, Oshima Y, et al. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. J Biol Chem. 2006;281(10):6442\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"1177_CR57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcp.10137","volume":"192","author":"T Hirobe","year":"2002","unstructured":"Hirobe T. Role of leukemia inhibitory factor in the regulation of the proliferation and differentiation of neonatal mouse epidermal melanocytes in culture. J Cell Physiol. 2002;192(3):315\u201326.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1177_CR58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/jir.1995.15.455","volume":"15","author":"D Paglia","year":"1995","unstructured":"Paglia D, Oran A, Lu C, Kerbel RS, Sauder DN, McKenzie RC. Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated. J Interferon Cytokine Res. 1995;15(5):455\u201360.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"1177_CR59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2010.04.021","volume":"297","author":"D Arthan","year":"2010","unstructured":"Arthan D, Hong SK, Park JI. Leukemia inhibitory factor can mediate Ras\/Raf\/MEK\/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells. Cancer Lett. 2010;297(1):31\u201341.","journal-title":"Cancer Lett"},{"issue":"2","key":"1177_CR60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.exer.2006.01.027","volume":"83","author":"JR McColm","year":"2006","unstructured":"McColm JR, Geisen P, Peterson LJ, Hartnett ME. Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis. Exp Eye Res. 2006;83(2):438\u201346.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1177_CR61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/excr.2002.5666","volume":"282","author":"C Schere-Levy","year":"2003","unstructured":"Schere-Levy C, Buggiano V, Quaglino A, Gattelli A, Cirio MC, Piazzon I, et al. Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res. 2003;282(1):35\u201347.","journal-title":"Exp Cell Res"},{"issue":"5","key":"1177_CR62","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/jnr.21919","volume":"87","author":"C Moon","year":"2009","unstructured":"Moon C, Liu BQ, Kim SY, Kim EJ, Park YJ, Yoo JY, et al. Leukemia inhibitory factor promotes olfactory sensory neuronal survival via phosphoinositide 3-kinase pathway activation and Bcl-2. J Neurosci Res. 2009;87(5):1098\u2013106.","journal-title":"J Neurosci Res"},{"issue":"6","key":"1177_CR63","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.yexcr.2009.11.022","volume":"316","author":"LC Hunt","year":"2010","unstructured":"Hunt LC, Tudor EM, White JD. Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis. Exp Cell Res. 2010;316(6):1002\u20139.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1177_CR64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2044-5040-1-17","volume":"1","author":"LC Hunt","year":"2011","unstructured":"Hunt LC, Upadhyay A, Jazayeri JA, Tudor EM, White JD. Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation. Skelet Muscle. 2011;1(1):17.","journal-title":"Skelet Muscle"},{"issue":"12","key":"1177_CR65","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI31871","volume":"117","author":"SP Gao","year":"2007","unstructured":"Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest. 2007;117(12):3846\u201356.","journal-title":"J Clin Invest"},{"issue":"2","key":"1177_CR66","first-page":"594","volume":"9","author":"M Dolled-Filhart","year":"2003","unstructured":"Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Clin Cancer Res. 2003;9(2):594\u2013600.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1177_CR67","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1158\/1078-0432.CCR-09-2658","volume":"16","author":"E Pectasides","year":"2010","unstructured":"Pectasides E, Egloff AM, Sasaki C, Kountourakis P, Burtness B, Fountzilas G, et al. Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin Cancer Res. 2010;16(8):2427\u201334.","journal-title":"Clin Cancer Res"},{"issue":"35","key":"1177_CR68","doi-asserted-by":"crossref","first-page":"E2361","DOI":"10.1073\/pnas.1201232109","volume":"109","author":"JP Couto","year":"2012","unstructured":"Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simoes M, et al. STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A. 2012;109(35):E2361\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1177_CR69","first-page":"413","volume":"35","author":"WG Kim","year":"2012","unstructured":"Kim WG, Choi HJ, Kim WB, Kim EY, Yim JH, Kim TY, et al. Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas. J Endocrinol Invest. 2012;35(4):413\u20138.","journal-title":"J Endocrinol Invest"},{"key":"1177_CR70","doi-asserted-by":"crossref","unstructured":"Tas F, Yasasever CT, Karabulut S, Tastekin D, Duranyildiz D. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer. Tumour Biol. 2014. [Epub ahead of print].","DOI":"10.1007\/s13277-014-2817-9"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1177-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1177-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:09:16Z","timestamp":1630577356000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1177-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,29]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1177-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,29]]},"assertion":[{"value":"12 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"200"}}